Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Income from Continuing Operations: 2009-2025

Historic Income from Continuing Operations for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$1.9 million.

  • Cumberland Pharmaceuticals' Income from Continuing Operations fell 26.81% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 69.22%. This contributed to the annual value of -$6.4 million for FY2024, which is 1.78% down from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Income from Continuing Operations stood at -$1.9 million, which was down 165.10% from -$735,207 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Income from Continuing Operations ranged from a high of $1.2 million in Q1 2025 and a low of -$6.3 million during Q4 2023.
  • In the last 3 years, Cumberland Pharmaceuticals' Income from Continuing Operations had a median value of -$1.1 million in 2024 and averaged -$1.3 million.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Income from Continuing Operations plummeted by 1,204.25% in 2024 and then surged by 165.61% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Income from Continuing Operations (Quarterly) stood at -$4.4 million in 2021, then surged by 43.94% to -$2.5 million in 2022, then plummeted by 156.21% to -$6.3 million in 2023, then soared by 69.82% to -$1.9 million in 2024, then decreased by 26.81% to -$1.9 million in 2025.
  • Its Income from Continuing Operations was -$1.9 million in Q3 2025, compared to -$735,207 in Q2 2025 and $1.2 million in Q1 2025.